The Report
Deep dives into company funding, growth strategies, and market insights from the world's most innovative businesses
1,101 reports and counting
AbCellera Raises $555M in Series B
AbCellera, a Biotech company based in 2389 Health Sciences Mall, Vancouver, BC V6T 1Z3, Canada, has raised $555M in Series B at a $5.7B valuation led by Peter Thiel, Eli Lilly, Fast Forward Innovations, DCVC Bio.
Apreo Health Raises $130M in Series B
Apreo Health, a HealthTech company based in Menlo Park, CA, has raised $130M in Series B led by Bain Capital Life Sciences, Norwest Venture Partners.
Verily Life Sciences raises $1B Series D at $6B valuation
Verily Life Sciences raises $1B in Series D at $6B valuation. Precision health and life sciences research...
Linus Health secures $55M Series B for healthcare innovation
Linus Health raises $55M in Series B funding to advance its digital brain health assessment platform and accelerate market growth.
AbCellera raises $555M Series B at $5.7B valuation
AbCellera raises $555M in Series B at $5.7B valuation. Antibody discovery platform...
Happify Health Headquarters - Office Location & Address
Discover Happify Health's headquarters at 51 E 12th St, New York, NY 10003. Digital therapeutics company offering science-based tools and programs for emotional wellbeing. Platform delivering game-based interventions for anxiety, depression, and chronic health conditions through employers and health plans.. Learn about the office facilities and work environment.
Apreo Health raises $130M Series B
Apreo Health raises $130M in Series B. Clinical-stage company developing novel treatment for severe emphysema...
Verily Life Sciences Raises $1B in Series D
Verily Life Sciences, a HealthTech company based in South San Francisco, CA, has raised $1B in Series D at a $6B valuation led by Temasek, Silver Lake, Ontario Teachers.
Lila Sciences raises $200M Seed
Lila Sciences raises $200M in Seed. Science superintelligence platform...
Showing 9 reports • Page 1 • Category: all
Stay ahead of the market
Get weekly insights delivered to your inbox. No spam, just intelligence.